Company Overview
ANIKA THERAPEUTICS, INC.
ANIKRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
113M
2025 FY
Net Income
-11M
2025 FY
Shares Outstanding
14M
2025 FY
EPS
-0.76USD
2025 FY
Company Information
SIC Code
3841
CIK Code
898437
Exchange
Nasdaq
Location
US